Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Veru Inc (VERU)

Veru Inc (VERU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Veru to Present at ObesityWeek: Meta-Analysis of 4 Previous Randomized Clinical Trials that Support the Potential of Enobosarm to Optimize Weight Loss

VERU : 0.7337 (-3.90%)
Veru to Deliver Keynote Presentation on the Scientific Support for Enobosarm in Combination with GLP-1 Receptor Agonist to Preserve Muscle for Higher Quality Weight Loss at the 4th Edition of the World Obesity and Weight Management Congress

VERU : 0.7337 (-3.90%)
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market

EQNX::TICKER_START (NYSE:NNVC),(NASDAQ:BCRX),(NASDAQ:VERU),(NASDAQ:CMRX),(NASDAQ:SIGA) EQNX::TICKER_END

BCRX : 7.35 (-12.81%)
NNVC : 1.4700 (+3.52%)
VERU : 0.7337 (-3.90%)
CMRX : 0.9900 (unch)
SIGA : 7.00 (-2.91%)
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market

NNVC : 1.4700 (+3.52%)
VERU : 0.7337 (-3.90%)
CMRX : 0.9900 (unch)
SIGA : 7.00 (-2.91%)
3 Standout Penny Stocks to Watch This April

Investing in penny stocks carries substantial risk, but also offers the potential for significant returns. These penny stocks, all with bullish analyst ratings, have considerable upside potential, according...

OCGN : 0.9575 (+0.86%)
VERU : 0.7337 (-3.90%)
DM : 4.92 (unch)
$SPX : 5,712.69 (-0.28%)
Stock Index Futures Move Higher As Dovish Fed Comments Boost Hopes Of Fed Pivot

March S&P 500 futures (ESH23) are up +0.21%, and March Nasdaq 100 E-Mini futures (NQH23) are up +0.34% this morning after three major U.S. benchmark indices closed higher on Thursday as investors cheered...

ESH23 : 3,957.05s (-0.09%)
NQZ24 : 20,113.25 (+0.14%)
CRM : 298.01 (+1.12%)
TSLA : 242.84 (-2.47%)
LHA.D.DX : 6.240 (+1.56%)
AI : 24.84 (-0.76%)
VERU : 0.7337 (-3.90%)
CHPT : 1.3300 (+7.26%)
COST : 886.07 (+1.00%)
MRVL : 84.38 (-0.46%)
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Veru Inc. (VERU) Investors of Class Action and to Actively Participate

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Veru Inc. (“Veru” or the “Company”) (NASDAQ: VERU) and certain of...

VERU : 0.7337 (-3.90%)
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Veru Inc. (VERU)

The Law Offices of Frank R. Cruz reminds investors of the upcoming February 6, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Veru Inc. (“Veru”...

VERU : 0.7337 (-3.90%)
VERU SHAREHOLDER ALERT: Jakubowitz Law Reminds Veru Shareholders of a Lead Plaintiff Deadline of February 6, 2023

/PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Veru Inc. (NASDAQ: VERU). To...

VERU : 0.7337 (-3.90%)
VERU LAWSUIT ALERT: Levi & Korsinsky Notifies Veru Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Veru Inc. ("Veru" or the "Company") (NASDAQ: VERU) of a class action securities lawsuit. CLASS...

VERU : 0.7337 (-3.90%)

Barchart Exclusives

Is This High-Yield Dividend Stock a Buy After Earnings?
This pharmaceutical giant's Q3 numbers came in ahead of Street estimates. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar